With this kind of growth HH looking for 60-80 cents in cash flow coming up which will be translated into about 55 cents eps. P.E is 7x with groth approaching 75-100%+ as year progresses now that Sir Spheres is becoming standard of care in treating liver tumors. This is a huge earnings story and looking for $8 short term or 15x eps conservatively
huge revenue increase
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.42M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.5¢ | $3.789K | 28.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 197780 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 561008 | 8 |
View Market Depth
| Last trade - 11.22am 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
13.5¢ |
Change
0.000 ( 1.89 %) |
||||
| Open | High | Low | Volume | ||
| 13.5¢ | 13.5¢ | 13.5¢ | 5017 | ||
| Last updated 11.55am 14/06/2024 ? | |||||
| SRX (ASX) Chart |